(1.93 cm3, 21.50 mmol) in diethyl ether (20 cm3) and the mixture
stirred overnight. Water (100 cm3) was added and stirred for 2
h, then the organic layer decanted and the aqueous layer
washed with diethyl ether (2 × 20 cm3). The extracts were com-
bined and dried over MgSO4, filtered and subjected to column
chromatography using an 80% hexane–20% diethyl ether solu-
tion and isolated as an orange solid after evaporation of the
solvents. Overall yield from 1,1Ј-phenylphosphinoferroceno-
phane, 1.64 g (18%).
Method 2. A suspension of 1,1Ј-dilithioferrocene (6.75 g,
21.50 mmol) in hexane (100 cm3) was treated with a premixed
solution of (CH3)2S2 (1.93 cm3, 21.50 mmol) and P(C6H5)2Cl
(3.85 g, 21.50 mmol) in hexane (10 cm3) and the mixture stirred
overnight. Water (20 cm3) was added and stirred for 1 h, then
the organic layer decanted and the aqueous layer washed with
hexane (2 × 10 cm3). The extracts were combined and dried
over MgSO4, filtered, then purified by column chromatography
using first hexane (to remove the starting materials), then an
80% hexane–20% diethyl ether solution, to give the product,
after evaporation of the solvents, as a light orange microcrystal-
line powder. Further purification was achieved by recrystallis-
ation from hexane–diethyl ether (1:1) as orange crystals, 3.44 g
(38%) (Calc. for C23H21FePS: C, 66.35; H, 5.05. Found: C,
66.57; H, 4.87%). 1H NMR (CDCl3): δ 2.23 (s, 3 H, SCH3), 4.06
(t, 2 H, C5H4), 4.11 (q, 2 H, C5H4), 4.20 (t, 2 H, C5H4), 4.38 (t,
2 H, C5H4) and 7.31 (m, 10 H, C6H5). 31P-{1H} NMR (CDCl3):
δ Ϫ16.78.
[Cu(L3)2]PF6 5. From [Cu(CH3CN)4]PF6 (0.19 g, 0.52 mmol)
and ligand L3 (0.29 g, 1.04 mmol) in CH2Cl2 (20 cm3). The
resulting dark brown solution was reduced under vacuum,
washed with hexane (10 cm3) and dried to yield a brown crystal-
line solid, 0.38 g (96%) (Calc. for C24H28CuF6Fe2PS4: C, 37.65;
H, 3.66. Found: C, 37.48; H, 3.14%). 1H NMR (CDCl3): δ 2.68
(br s, 3 H, SCH3) and 4.43 (br s, 4 H, C5H4). m/z 620 [(L3)2Cu],
341 [(L3)Cu], 326 [(C5H4SMe)Fe(C5H4S)Cu] and 278 (L3).
Suitable crystals for X-ray analysis were grown as transparent
brown pyramids by cooling a saturated CH2Cl2 solution.
[Ag(L3)2]BF4 6. From [Ag(CH3CN)4]BF4 (0.30 g, 0.85 mmol)
and ligand L3 (0.47 g, 1.69 mmol). Dark brown solution
reduced under vacuum to a brown solid, 0.42 g (67%) (Calc. for
C24H28AgBF4Fe2S4: C, 38.35; H, 3.73. Found: C, 38.10; H,
3.74%). 1H NMR (CDCl3): δ 2–3 (br s, 3 H, SCH3) and 4–5 (m,
4 H, C5H4). m/z 664 [(L3)2Ag], 385 [(L3)Ag] and 278 (L3).
[Cu(L4)2]PF6 7. From ligand L4 (0.52 g, 1.56 mmol) and
[Cu(CH3CN)4]PF6 (0.29 g, 0.78 mmol). Dark brown oily solid
formed on evaporation of solvent, brown solid formed on cool-
ing, 0.53 g (78%) (Calc. for C32H44CuF6Fe2PS4: C, 43.79; H,
5.02. Found: C, 43.82; H, 5.06%). 1H NMR (CDCl3): δ 1.39 [d,
6 H, SCH(CH3)2], 3.30 [septet, 1 H, SCH(CH3)2], 4.40 (br, 2 H,
C5H4) and 4.51 (br, 2 H, C5H4). m/z 732 [(L4)2Cu], 471
[(L4)CuC5H4SCH(CH3)2Fe(C5H4)], 397 [(L4)Cu] and 334 (L4).
[Ag(L4)2]BF4 8. From ligand L4 (0.41 g, 1.2 mmol) and
[Ag(CH3CN)4]BF4 (0.22 g, 0.61 mmol). Light orange solid, 0.38
g (72%) (Calc. for C32H44AgBF4Fe2S4: C, 44.50; H, 5.10. Found:
C, 44.41; H, 4.84%). 1H NMR (CDCl3): δ 1.38 [d, 6 H,
SCH(CH3)2], 3.22 [septet, 1 H, SCH(CH3)2], 4.34 (t, 2 H, C5H4)
and 4.52 (t, 2 H, C5H4). m/z 776 [(L4)2Ag], 472 [(L4)AgS], 442
[(L4)Ag], 398 [AgC5H4SCH(CH3)2)Fe(C5H4)S] and 334 (L4).
Complexes
Formation of the complexes followed the same general pro-
cedure as for the formation of 5 using either [Cu(CH3CN)4]PF6
or [Ag(CH3CN)4]BF4 and the appropriate bidentate ligand.
[Cu(L1)2]PF6 1. The salt [Cu(CH3CN)4]PF6 (0.09 g, 2.33
mmol) was added to a solution of ligand L1 (0.19 g, 4.66 mmol)
in CH2Cl2 (20 cm3) and stirred for 1 h. The resulting dark brown
solution was reduced under vacuum, washed with diethyl ether
(10 cm3) and dried (MgSO4) to yield a brown microcrystalline
solid, 0.16 g (66%) (Calc. for C46H42CuF6Fe2P3S2: C, 53.03; H,
[Cu(L3){P(C6H5)3}2]PF6 9. A solution of [Cu(L3)2]PF6 (0.35 g,
4.58 mmol) was treated with P(C6H5)3 (0.24 g, 9.15 mmol) and
stirred for 1 h. The solution was reduced under vacuum and
washed with diethyl ether (2 × 10 cm3) to leave an orange solid,
0.31 g (67%) (Calc. for C48H44CuF6FeP3S2: C, 56.97; H, 4.35.
Found: C, 57.71; H, 4.36%). 1H NMR (CDCl3): δ 2.29 (s, 6 H,
SCH3), 4.31 (t, 4 H, C5H4), 4.95 (t, 4 H, C5H4), 7.11 (m, 15 H,
C6H5) and 7.41 (m, 15H, C6H5). m/z 603 [(L3)Cu(PPh3)], 587
[Cu(PPh3)2], 341 [(L3)Cu] and 278 (L3).
1
4.04. Found: C, 53.02, H, 4.31%). H NMR (CDCl3): δ 2.61
(br, 3 H, SCH3), 4.29 (br, 4 H, C5H4), 4.50 (br, 2 H, C5H4), 4.65
(br, 2 H, C5H4), 7.41 (br, 5 H, C6H5) and 7.58 (br, 5 H, C6H5).
m/z 896 [(L1)2Cu], 480 [(L1)Cu], 416 (L1).
[Ag(L1)2]BF4 2. From the salt [Ag(CH3CN)4]BF4 (0.14 g, 3.80
mmol) and ligand L1 (0.32 g, 7.64 mmol). Orange microcrystal-
line solid, 0.30 g (77%) (Calc. for C46H42AgBF4Fe2P2S2: C,
53.75; H, 4.09. Found: C, 54.09; H, 4.07%). 1H NMR (CDCl3):
δ 2.22 (s, 3 H, SCH3), 4.14 (t, 2 H, C5H4), 4.19 (t, 2 H, C5H4),
4.29 (t, 2 H, C5H4), 4.61 (t, 2 H, C5H4) and 7.45 (m, 10 H,
C6H5). m/z 941 [(L1)2Ag], 523 [(L1)Ag], 416 (L1) and 401
[(C5H4PPh2)Fe(C5H4S)].
X-Ray crystallography
Table 2 provides a summary of the crystal data, data collection
and refinement parameters for complexes 4 and 5. The struc-
tures were solved by direct methods and the heavy atom method
for 5 and 4 respectively, and refined by full matrix least squares
based on F 2. In 5 the complex and the PF6 anion were found to
be disordered over independent crystallographic S4 positions. In
the case of the complex two discrete half-occupancy orien-
tations were identified, with only their copper and iron centres
in common, and refined anisotropically, with the cyclopentadi-
enyl rings treated as optimised rigid bodies. The disorder in the
anion was modelled by the assignment of sufficient electron
density around the central phosphorus atom to match a single
quarter-occupancy (due to site symmetry) molecule, all atoms
being refined anisotropically. In 4 the complex was ordered
and refined anisotropically with the phenyl rings treated as
optimised rigid bodies (the cyclopentadienyl rings were not opti-
mised). The BF4 anion was found to be distributed over three
partial occupancy sites (two of which were located proximal to
crystallographic special positions); only the major occupancy
atoms were refined anisotropically. In both structures the
hydrogen atoms were placed in calculated positions, assigned
isotropic thermal parameters, U(H) = 1.2Ueq(C), and allowed to
[Cu(L2)2]PF6 3. From the salt [Cu(CH3CN)4]PF6 (0.07 g, 1.81
mmol) and ligand L2 (0.20 g, 3.61 mmol). The complex was
allowed to recrystallise from the CH2Cl2 solution, producing
light orange crystals, 0.17 g (71%) (Calc. for C68H56CuF6Fe2P5:
C, 61.96: H, 4.25. Found: C, 61.64; H, 4.60%). 1H NMR
(CDCl3): δ 4.10 (br, 4 H, C5H4), 4.31 (br, 4 H, C5H4), 7.25 (m, 10
H, C6H5) and 7.40 (m, 10 H, C6H5). m/z 1172 [(L2)2Cu], 617
[(L2)Cu] and 554 (L2).
[Ag(L2)2]BF4 4. From ligand L2 (0.10 g, 0.18 mmol) and
[Ag(CH3CN)4]BF4 (0.03 g, 0.09 mmol). Light orange solid,
0.076 g (65%) (Calc. for C68H56AgBF4Fe2P4: C, 62.62; H, 4.30.
Found: C, 62.66; H, 3.95%). 1H NMR (CDCl3): δ 4.10 (br, 4 H,
C5H4), 4.40 (br, 4 H, C5H4), 7.10 (m, 10 H, C6H5) and 7.30 (m,
10 H, C6H5). m/z 1216 [(L2)2Ag], 1139 [(L2)Ag(C5H4PPh2)-
Fe(C5H4PPh)], 661 [(L2)Ag] and 554 (L2).
1982
J. Chem. Soc., Dalton Trans., 1999, 1981–1986